← FDA DRUG APPROVALS

FDA ANDA · ANDA209235

IBUPROFEN AND PSEUDOEPHEDRINE HCL

Sponsor: AUROBINDO PHARMA

APPLICATION
ANDA209235
TYPE
ANDA
ORIGINAL APPROVAL
2017-12-01
LATEST ACTION
2017-12-01
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Over-the-counter

Products

IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDEOver-the-counter
IBUPROFEN EQ 200MG FREE ACID AND POTASSIUM SALT, PSEUDOEPHEDRINE HYDROCHLORIDE 30MG · CAPSULE · ORAL

Approval history

2017-12-01UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →